Literature DB >> 1407700

Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin.

A Szallasi1, P M Blumberg.   

Abstract

A dose-dependent loss of vanilloid receptors (specific [3H]resiniferatoxin binding sites) was found in sensory ganglia of rats 24 h after s.c. administration of resiniferatoxin (RTX), an ultrapotent capsaicin analog. This receptor loss displayed an ED50 of 30 micrograms/kg both in dorsal root and trigeminal ganglia; the ED50 was 6-fold higher than the ED50 for loss of the neurogenic inflammatory response and 30-60-fold higher than the ED50 for desensitization in the standard eye-wiping (chemogenic pain) response. The receptor loss appeared later (24 h) than the loss of the physiological responses (6 h) and showed modest recovery (to 20-30% of control levels) over the following 4 weeks. This vanilloid receptor loss may represent a novel, specific mechanism for vanilloid-induced chronic desensitization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407700     DOI: 10.1016/0304-3940(92)90679-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovacs; Jeffrey D Pasley; Myra G Nunez; Alice A Larson
Journal:  Neuropharmacology       Date:  2013-04-25       Impact factor: 5.250

Review 2.  Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.

Authors:  Magdalene M Moran; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

3.  Activation of TRPV1 in nucleus tractus solitarius reduces brown adipose tissue thermogenesis, arterial pressure, and heart rate.

Authors:  Mazher Mohammed; Christopher J Madden; Michael C Andresen; Shaun F Morrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

Review 4.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

5.  Cardiac Afferent Denervation Abolishes Ganglionated Plexi and Sympathetic Responses to Apnea: Implications for Atrial Fibrillation.

Authors:  Liliana Tavares; Moisés Rodríguez-Mañero; Bahij Kreidieh; Sergio H Ibarra-Cortez; Jiexiao Chen; Sufen Wang; Judit Markovits; Roberto Barrios; Miguel Valderrábano
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-06-05

Review 6.  Sleep Apnea and Atrial Fibrillation: Role of the Cardiac Autonomic Nervous System.

Authors:  Liliana Tavares; Adi Lador; Miguel Valderrábano
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

7.  Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences.

Authors:  A Szallasi; B Conte; C Goso; P M Blumberg; S Manzini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

8.  [3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents.

Authors:  A Szallasi; P M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

Review 9.  Vanilloid-induced conduction analgesia: selective, dose-dependent, long-lasting, with a low level of potential neurotoxicity.

Authors:  Igor Kissin
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

10.  The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis.

Authors:  Eugene Y Kissin; Cristina F Freitas; Igor Kissin
Journal:  Anesth Analg       Date:  2005-11       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.